Wegovy and Ozempic vs Weight Loss Surgery
An honest, side-by-side comparison. GLP-1 medications and bariatric surgery both help with weight loss, but they work differently, cost differently, and deliver different long-term results.
If you are researching weight loss options, you have almost certainly come across Wegovy and Ozempic. These GLP-1 receptor agonist medications have changed the conversation around weight management, and for good reason, they genuinely work for many people.
But so does weight loss surgery. And the two options work in fundamentally different ways, cost very different amounts over time, and produce different long-term outcomes.
This page is not here to sell you surgery over medication, or the other way around. It is here to give you the clear, factual comparison you need to make the right decision for your individual circumstances. Both options have a place. The question is which one is right for you.
At The Health Store Turkey, we believe you deserve honest information, not a sales pitch. If medication is the better option for you, we will say so. If surgery makes more sense, we will explain why. Your patient coordinator can help you weigh up both options based on your BMI, health history, and personal goals.
What Is Wegovy and Ozempic vs Weight Loss Surgery?
What Are Wegovy and Ozempic?
Wegovy and Ozempic are brand names for semaglutide, a GLP-1 receptor agonist medication. GLP-1 is a hormone your body produces naturally after eating, it signals to your brain that you are full and slows down the emptying of your stomach.
Semaglutide mimics this hormone at much higher levels than your body produces naturally. The result is a significant reduction in appetite and food cravings, leading to weight loss.
- Ozempic was originally developed and licensed for type 2 diabetes management. It is prescribed off-label for weight loss at lower doses (up to 1mg weekly).
- Wegovy is the same active ingredient (semaglutide) but is specifically licensed for weight management at a higher dose (2.4mg weekly). It was approved by NICE (TA875) in 2023 for adults with a BMI of 35+ (or 30+ with a weight-related comorbidity).
Both are administered as a weekly injection, typically self-injected into the abdomen, thigh, or upper arm using a pre-filled pen.
How Does Weight Loss Surgery Compare?
Weight loss surgery, such as a gastric sleeve, gastric bypass, or gastric balloon, works by physically changing your digestive system. Depending on the procedure:
- Gastric sleeve, Removes approximately 80% of your stomach, reducing capacity and hunger hormones. From £2,770 at The Health Store Turkey.
- Gastric bypass, Creates a small stomach pouch and reroutes the intestine, reducing both food intake and calorie absorption. From £4,500.
- Gastric balloon, A temporary, non-surgical inflatable balloon placed in your stomach to reduce capacity. From £2,000.
Surgery produces permanent structural changes (gastric sleeve and bypass) or temporary restriction (gastric balloon, typically 6-12 months). GLP-1 medications work only while you continue taking them.
The Key Difference
This is the single most important distinction: surgery is a one-time intervention with permanent effects. GLP-1 medication requires ongoing, indefinite use to maintain results.
When you stop taking Wegovy or Ozempic, the appetite suppression stops. Clinical trial data (STEP 1 extension study) shows that approximately two-thirds of patients regain most of their lost weight within 12 months of discontinuing the medication. Surgery, by contrast, permanently changes the size and function of your stomach.
Am I Suitable?
Who Is Suitable for GLP-1 Medications?
According to NICE guidance (TA875), Wegovy may be prescribed on the NHS for adults who meet the following criteria:
- BMI of 35 or above, or
- BMI of 30-34.9 with at least one weight-related comorbidity (such as type 2 diabetes, high blood pressure, or sleep apnoea)
- Have been through a specialist weight management service
Private prescriptions are available more broadly, typically from BMI 27+ with a comorbidity or BMI 30+.
Important NHS limitation: NICE currently limits NHS-funded Wegovy prescriptions to a maximum of 2 years. After that, you either fund the medication privately or stop taking it, with the associated risk of weight regain.
Who Is Suitable for Weight Loss Surgery?
NICE guidance (NG246) recommends bariatric surgery for adults who meet these criteria:
- BMI of 35 or above with obesity-related comorbidities, or
- BMI of 40 or above regardless of comorbidities, or
- BMI of 30-34.9 with recent-onset type 2 diabetes
At The Health Store Turkey, eligibility is assessed individually:
- Gastric balloon, from BMI 27+
- Gastric sleeve, from BMI 30+ (or 27+ with comorbidities)
- Gastric bypass, typically from BMI 35+ (or 30+ with comorbidities such as type 2 diabetes)
Who Might Benefit Most from Each Option?
GLP-1 medications may suit you better if:
- Your BMI is in the lower overweight range (27-30)
- You prefer a non-surgical approach
- You have a relatively small amount of weight to lose (1-3 stone)
- You are willing and able to fund ongoing medication costs
- You have tried lifestyle changes alone but need additional support
Surgery may suit you better if:
- Your BMI is 30 or above
- You have a significant amount of weight to lose (4+ stone)
- You want a one-time solution rather than ongoing medication
- You have obesity-related health conditions that would benefit from rapid, sustained weight loss
- You have tried other methods, including potentially GLP-1 medications, without lasting results
- Long-term medication cost or availability is a concern
What Happens During the Procedure?
The Wegovy/Ozempic Journey
Getting started: You obtain a prescription either through a specialist NHS weight management service (if eligible) or through a private provider. The medication is gradually increased over 16-20 weeks to the maintenance dose, allowing your body to adjust and minimise side effects.
Ongoing treatment: You self-inject once per week. Most people inject on the same day each week at a time that suits them. You continue with the medication indefinitely to maintain weight loss. If you stop, appetite returns to pre-treatment levels.
Monitoring: Regular check-ins with your prescriber to monitor weight loss, side effects, and overall health. Blood tests may be recommended periodically.
Typical weight loss: Clinical trials show average weight loss of 12-15% of total body weight over 68 weeks (approximately 16 months). For a person weighing 16 stone, that is roughly 2-2.5 stone.
The Surgical Journey
Getting started: A free consultation with The Health Store Turkey, followed by a medical review and pre-operative preparation (including a 2-week liver-shrinking diet for gastric sleeve or bypass).
The procedure: Performed in a JCI-accredited hospital under general anaesthesia. A gastric sleeve takes 45-60 minutes; a gastric bypass takes 60-90 minutes. You stay in hospital for 2-4 nights depending on the procedure.
Recovery: Most patients return to normal activities within 2-4 weeks. You follow a phased dietary programme as your body adjusts.
Typical weight loss: Gastric sleeve patients lose 60-70% of excess body weight within 12-18 months. Gastric bypass patients lose 70-80%. For a person who is 6 stone overweight, a gastric sleeve could mean losing 4-5 stone.
Aftercare: 12 months of dedicated aftercare, including UK aftercare clinics with NHS-registered wound care specialists, 24/7 remote support, dietary guidance, and regular check-ins.
Side-by-Side Comparison
| Factor | Wegovy/Ozempic | Gastric Sleeve |
|---|---|---|
| How it works | Weekly injection suppresses appetite | Permanent stomach reduction (80% removed) |
| Typical weight loss | 12-15% of total body weight | 60-70% of excess body weight |
| Time to full results | 16-20 months | 12-18 months |
| Permanence | Only while taking medication | Permanent |
| Weight regain risk | ~67% regain within 12 months of stopping | 10-20% regain over 5 years (manageable) |
| Procedure required | No | Yes (45-60 min, general anaesthesia) |
| Recovery time | None | 2-4 weeks |
| Hospital stay | None | 2-3 nights |
| Ongoing medication | Weekly injection, indefinitely | Daily vitamins only |
Recovery & Aftercare
Recovery: A Direct Comparison
Wegovy/Ozempic: There is no recovery period. You begin the medication and continue your normal daily routine. Side effects (primarily nausea, which affects 40-50% of users) are most common during the dose escalation phase and typically settle within a few weeks. No time off work is required.
Gastric Sleeve Surgery: You will need 2-3 weeks off work for a desk-based role, or 3-4 weeks for a physical role. The first 1-2 weeks involve a liquid diet and light activity. By weeks 2-4, you transition to soft foods and resume most normal activities. By month 2-3, you are eating small regular meals and the weight loss is accelerating significantly.
The Long-Term Picture
This is where the comparison becomes most important.
Wegovy/Ozempic at 1 year: You are maintaining your weight loss while continuing weekly injections. Your annual cost is £2,160-£3,588 (at £180-£299/month). You are reliant on continued supply and continued funding.
Gastric sleeve at 1 year: You have lost the majority of your excess weight. Your one-time cost of £2,770 is behind you. You take a daily multivitamin. Your aftercare programme is nearing completion. Your stomach remains permanently smaller.
Wegovy/Ozempic at 5 years: Total spend: £10,800-£17,940. If you stop at any point, clinical data suggests approximately two-thirds of the weight returns within 12 months.
Gastric sleeve at 5 years: Total spend: £2,770 (plus minimal vitamin costs). Long-term data shows sustained weight loss of 50-60% of excess body weight at 5 years for the majority of patients.
Wegovy/Ozempic at 10 years: Total spend: approximately £21,600-£35,880. Long-term data beyond 5 years is limited, as the medication is relatively new.
Gastric sleeve at 10 years: Total spend: still £2,770. Over two decades of clinical data supports sustained long-term results.
The Cost Comparison
| Timeframe | Wegovy (mid-range £240/month) | Gastric Sleeve (THST) |
|---|---|---|
| Year 1 | £2,880 | £2,770 (one-time) |
| Break-even point | ~12 months | |
| Year 2 | £5,760 | £2,770 |
| Year 5 | £14,400 | £2,770 |
| Year 10 | £28,800 | £2,770 |
The break-even point is approximately 12 months. After that, every month on GLP-1 medication is additional cost with no additional benefit that surgery would not have already provided permanently.
Risks & Considerations
Risks of GLP-1 Medications
Wegovy and Ozempic are generally well-tolerated, but they carry their own risk profile:
Common side effects (affecting 10%+ of users):
- Nausea (up to 44% of users, particularly during dose escalation)
- Diarrhoea, constipation, and abdominal discomfort
- Headaches
- Fatigue
Less common but notable risks:
- Pancreatitis, rare but serious. Seek immediate medical attention for severe abdominal pain.
- Gallbladder problems, weight loss itself (by any method) increases gallstone risk
- Thyroid concerns, GLP-1 medications carry a boxed warning regarding thyroid C-cell tumours (observed in animal studies; human significance not yet confirmed)
- Muscle loss, a proportion of weight lost on GLP-1 medications is lean muscle mass, not just fat. This can affect strength, metabolism, and long-term health.
- Psychological effects, some patients report mood changes, and the relationship with food can become complicated when appetite is chemically suppressed
Supply and access risks:
- Ongoing global supply shortages have affected availability
- NHS funding is time-limited (maximum 2 years under NICE TA875)
- Private costs may increase over time
- Stopping the medication typically leads to weight regain
Risks of Weight Loss Surgery
Common side effects (temporary):
- Nausea and discomfort in the first few days (managed with medication)
- Fatigue during the liquid diet phase
- Acid reflux in some patients (usually temporary)
- Sensitivity to certain foods as you reintroduce solids
Less common risks:
- Infection at incision sites (minimised by JCI hospital hygiene standards)
- Blood clots (reduced by early mobilisation and compression stockings)
- Staple line leak (approximately 1-2% of cases, monitored closely during hospital stay)
- Nutritional deficiencies (managed with daily supplements and regular blood tests)
How surgical risks are managed:
- JCI-accredited hospitals with on-site ICU
- Experienced surgical teams performing procedures regularly
- 2-3 night hospital stay with post-operative monitoring
- 12-month aftercare programme including nutritional support
- Mandatory complication insurance from January 2026
A Fair Assessment
Neither option is risk-free. GLP-1 medications avoid surgical risk but introduce ongoing pharmaceutical dependency and the near-certainty of weight regain if you stop. Surgery carries the inherent risks of a procedure under general anaesthesia but delivers a permanent result with a well-established, decades-long safety record.
Your decision should be based on your individual health profile, the amount of weight you need to lose, your tolerance for ongoing medication, and your long-term goals. Your patient coordinator can help you think through these factors honestly.
UK Aftercare: We Are Here When You Get Home
Unlike other medical tourism companies, we do not leave you on your own once you are back in the UK. We have two dedicated aftercare clinics staffed by NHS-registered wound care specialists, so you can see a professional face-to-face for wound checks, dressing changes, and recovery support.
Medical disclaimer: Results of any surgical or interventional procedure may vary from person to person. You are advised to consult your physician for detailed information before undergoing any procedure. The information on this page is for general guidance only and does not constitute medical advice. See our Medical Disclaimer for full details.
The Cost Comparison: One-Time vs Ongoing
The most significant difference between medication and surgery is not the monthly cost, it is the lifetime cost. Here is the reality.
Wegovy / Ozempic
- Year 1: £2,160-£3,588
- Year 3: £6,480-£10,764
- Year 5: £10,800-£17,940
- Must continue indefinitely
- ~67% regain weight within 12 months of stopping
- Subject to supply shortages and price changes
Gastric Sleeve Surgery
- One-time payment, nothing more to pay
- 60-70% excess weight loss in 12-18 months
- Permanent stomach reduction
- Saves £8,000-£15,000 vs 5 years of medication
- All-inclusive package at a government-licensed hospital
- 12 months of dedicated aftercare included
Neither option is right for everyone. If your BMI is under 30, medication may be the better path. If your BMI is 30 or above and you want a permanent solution without ongoing costs, surgery delivers significantly more weight loss at a fraction of the long-term price. Your patient coordinator can help you weigh up both options honestly, no pressure, just the facts.
What Our Patients Say
Real reviews from real patients. Their words, not ours.
"They discovered severe hypertension during my pre-op testing and additional tests ensured my safety. They genuinely put patient health first."
"The 24-hour staff support was reassuring. The care was exceptional throughout and I am already planning my return."
"Excellent, caring staff. I felt at ease from the moment I arrived. The English communication was excellent."
Frequently Asked Questions
It depends on what you mean by "better." Wegovy produces meaningful weight loss (12-15% of total body weight) with no surgery and no recovery time. A gastric sleeve produces greater total weight loss (60-70% of excess body weight) through a one-time procedure. The critical difference is permanence: Wegovy works only while you take it, and approximately two-thirds of patients regain weight within 12 months of stopping. A gastric sleeve permanently changes the size of your stomach. For patients with a BMI of 30+ and significant weight to lose, surgery typically produces superior long-term outcomes. For patients with a lower BMI or those who prefer to avoid surgery, Wegovy may be appropriate.
Wegovy costs £180-£299 per month privately in the UK. Over 10 years, that totals approximately £21,600-£35,880. A gastric sleeve at The Health Store Turkey costs from £2,770 as a one-time, all-inclusive package, covering the procedure, hospital stay, 5-star hotel, airport transfers, personal translator, and 12 months of aftercare. The break-even point is approximately 12 months. After that, every month on Wegovy is additional cost. On the NHS, Wegovy is currently limited to a maximum of 2 years (NICE TA875), after which you either fund it privately or stop, with the associated risk of weight regain.
When you stop taking GLP-1 medications, the appetite-suppressing effect stops. Your hunger and food cravings return to pre-treatment levels. Clinical trial data (the STEP 1 extension study) shows that approximately two-thirds of patients regain most of their lost weight within 12 months of discontinuing the medication. This is not a failure of willpower, it is the biological reality of how these medications work. They manage appetite while you take them; they do not permanently change your physiology. This is the fundamental difference from surgery, which permanently reduces stomach size and hunger hormone production.
Yes, absolutely. Many patients come to The Health Store Turkey after trying GLP-1 medications and finding that the results were insufficient, the side effects were difficult to manage, or the ongoing cost was unsustainable. Having previously tried medication does not affect your suitability for surgery, in fact, some surgeons view it as evidence of your commitment to addressing your weight. Your patient coordinator can assess your situation and advise whether surgery is the right next step, taking into account your experience with medication, your current BMI, and your goals.
The NHS does fund bariatric surgery, but waiting lists are extremely long, often 2-4 years, and eligibility criteria are strict (typically BMI 40+, or BMI 35+ with comorbidities, after completing a Tier 3 weight management programme). NICE guidance (NG246) does recommend surgery as a treatment option for eligible patients. Wegovy is available on the NHS for a maximum of 2 years through specialist weight management services. Many patients choose to have surgery with The Health Store Turkey rather than wait for NHS funding, benefiting from the same clinical standards at a fraction of the UK private cost, from £2,770 for a gastric sleeve compared to £8,000-£12,000 privately in the UK.
Combine Treatments and Save
Many patients combine procedures in a single trip, reducing recovery time and overall cost. Build your personalised package and get a free quote.
Build Your Package →Find Your Perfect Treatment
Take our 2-minute quiz and get personalised recommendations based on your goals.
Take the Quiz →Still researching? Talk to people who have been where you are.
Our private Facebook community has over 8,000 members, past patients, people preparing for treatment, and others weighing up their options. Ask anything, read honest experiences, and make your decision with confidence. No sales pitch, just real people.